Methicillin-resistant staphylococcus aureus in Europe, 1999-2002

Edine W. Tiemersma, Stef L A M Bronzwaer, Outi Lyytikäinen, John E. Degener, Paul Schrijnemakers, Nienke Bruinsma, Jos Monen, Wolfgang Witte, Hajo Grundmann, H. Mittermayer, W. Koller, H. Goossens, E. Hendrickx, B. Markova, S. Kalenic, A. Tambic-Andrasevic, P. Urbaskova, D. Monnet, P. Naaber, O. LyytikäinenA. Nissinen, H. Aubry-Damon, P. Courvalin, U. Buchholz, W. Witte, N. Legakis, G. Vatopoulos, M. Füzi, D. O'Flanagan, O. Murphy, K. Kristinsson, R. Raz, G. Cornaglia, P. D'Ancona, R. Hemmer, M. Borg, A. De Neeling, E. Tiemersma, A. Hoiby, E. Bjørløw, W. Hryniewicz, M. Caniça, I. Codita, M. Gubina, J. Kolman, L. Langsadl, F. Baquero, J. Campos, B. Liljequist, A. Johnson, M. Whale

Research output: Contribution to journalArticle

441 Citations (Scopus)

Abstract

We explored the variation in proportions of methicillin-resistant Staphylococcus aureus (MRSA) between and within countries participating in the European Antimicrobial Resistance Surveillance System and temporal trends in its occurrence. This system collects routine antimicrobial susceptibility tests for S. aureus. We examined data collected from January 1999 through December 2002 (50,759 isolates from 495 hospitals in 26 countries). MRSA prevalence varied almost 100-fold, from 40% in southern and western Europe. MRSA proportions significantly increased in Belgium, Germany, Ireland, the Netherlands, and the United Kingdom, and decreased in Slovenia. Within countries, MRSA proportions varied between hospitals with highest variance in countries with a prevalence of 5% to 20%. The observed trends should stimulate initiatives to control MRSA at national, regional, and hospital levels. The large differences between hospitals indicate that efforts may be most effective at regional and hospital levels.

Original languageEnglish
Pages (from-to)1627-1634
Number of pages8
JournalEmerging Infectious Diseases
Volume10
Issue number9
Publication statusPublished - Sep 2004

Fingerprint

Methicillin-Resistant Staphylococcus aureus
Slovenia
Belgium
Ireland
Netherlands
Germany
Staphylococcus aureus

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Tiemersma, E. W., Bronzwaer, S. L. A. M., Lyytikäinen, O., Degener, J. E., Schrijnemakers, P., Bruinsma, N., ... Whale, M. (2004). Methicillin-resistant staphylococcus aureus in Europe, 1999-2002. Emerging Infectious Diseases, 10(9), 1627-1634.

Methicillin-resistant staphylococcus aureus in Europe, 1999-2002. / Tiemersma, Edine W.; Bronzwaer, Stef L A M; Lyytikäinen, Outi; Degener, John E.; Schrijnemakers, Paul; Bruinsma, Nienke; Monen, Jos; Witte, Wolfgang; Grundmann, Hajo; Mittermayer, H.; Koller, W.; Goossens, H.; Hendrickx, E.; Markova, B.; Kalenic, S.; Tambic-Andrasevic, A.; Urbaskova, P.; Monnet, D.; Naaber, P.; Lyytikäinen, O.; Nissinen, A.; Aubry-Damon, H.; Courvalin, P.; Buchholz, U.; Witte, W.; Legakis, N.; Vatopoulos, G.; Füzi, M.; O'Flanagan, D.; Murphy, O.; Kristinsson, K.; Raz, R.; Cornaglia, G.; D'Ancona, P.; Hemmer, R.; Borg, M.; De Neeling, A.; Tiemersma, E.; Hoiby, A.; Bjørløw, E.; Hryniewicz, W.; Caniça, M.; Codita, I.; Gubina, M.; Kolman, J.; Langsadl, L.; Baquero, F.; Campos, J.; Liljequist, B.; Johnson, A.; Whale, M.

In: Emerging Infectious Diseases, Vol. 10, No. 9, 09.2004, p. 1627-1634.

Research output: Contribution to journalArticle

Tiemersma, EW, Bronzwaer, SLAM, Lyytikäinen, O, Degener, JE, Schrijnemakers, P, Bruinsma, N, Monen, J, Witte, W, Grundmann, H, Mittermayer, H, Koller, W, Goossens, H, Hendrickx, E, Markova, B, Kalenic, S, Tambic-Andrasevic, A, Urbaskova, P, Monnet, D, Naaber, P, Lyytikäinen, O, Nissinen, A, Aubry-Damon, H, Courvalin, P, Buchholz, U, Witte, W, Legakis, N, Vatopoulos, G, Füzi, M, O'Flanagan, D, Murphy, O, Kristinsson, K, Raz, R, Cornaglia, G, D'Ancona, P, Hemmer, R, Borg, M, De Neeling, A, Tiemersma, E, Hoiby, A, Bjørløw, E, Hryniewicz, W, Caniça, M, Codita, I, Gubina, M, Kolman, J, Langsadl, L, Baquero, F, Campos, J, Liljequist, B, Johnson, A & Whale, M 2004, 'Methicillin-resistant staphylococcus aureus in Europe, 1999-2002', Emerging Infectious Diseases, vol. 10, no. 9, pp. 1627-1634.
Tiemersma EW, Bronzwaer SLAM, Lyytikäinen O, Degener JE, Schrijnemakers P, Bruinsma N et al. Methicillin-resistant staphylococcus aureus in Europe, 1999-2002. Emerging Infectious Diseases. 2004 Sep;10(9):1627-1634.
Tiemersma, Edine W. ; Bronzwaer, Stef L A M ; Lyytikäinen, Outi ; Degener, John E. ; Schrijnemakers, Paul ; Bruinsma, Nienke ; Monen, Jos ; Witte, Wolfgang ; Grundmann, Hajo ; Mittermayer, H. ; Koller, W. ; Goossens, H. ; Hendrickx, E. ; Markova, B. ; Kalenic, S. ; Tambic-Andrasevic, A. ; Urbaskova, P. ; Monnet, D. ; Naaber, P. ; Lyytikäinen, O. ; Nissinen, A. ; Aubry-Damon, H. ; Courvalin, P. ; Buchholz, U. ; Witte, W. ; Legakis, N. ; Vatopoulos, G. ; Füzi, M. ; O'Flanagan, D. ; Murphy, O. ; Kristinsson, K. ; Raz, R. ; Cornaglia, G. ; D'Ancona, P. ; Hemmer, R. ; Borg, M. ; De Neeling, A. ; Tiemersma, E. ; Hoiby, A. ; Bjørløw, E. ; Hryniewicz, W. ; Caniça, M. ; Codita, I. ; Gubina, M. ; Kolman, J. ; Langsadl, L. ; Baquero, F. ; Campos, J. ; Liljequist, B. ; Johnson, A. ; Whale, M. / Methicillin-resistant staphylococcus aureus in Europe, 1999-2002. In: Emerging Infectious Diseases. 2004 ; Vol. 10, No. 9. pp. 1627-1634.
@article{fe8944cfef2949c79073b5137d82f782,
title = "Methicillin-resistant staphylococcus aureus in Europe, 1999-2002",
abstract = "We explored the variation in proportions of methicillin-resistant Staphylococcus aureus (MRSA) between and within countries participating in the European Antimicrobial Resistance Surveillance System and temporal trends in its occurrence. This system collects routine antimicrobial susceptibility tests for S. aureus. We examined data collected from January 1999 through December 2002 (50,759 isolates from 495 hospitals in 26 countries). MRSA prevalence varied almost 100-fold, from 40{\%} in southern and western Europe. MRSA proportions significantly increased in Belgium, Germany, Ireland, the Netherlands, and the United Kingdom, and decreased in Slovenia. Within countries, MRSA proportions varied between hospitals with highest variance in countries with a prevalence of 5{\%} to 20{\%}. The observed trends should stimulate initiatives to control MRSA at national, regional, and hospital levels. The large differences between hospitals indicate that efforts may be most effective at regional and hospital levels.",
author = "Tiemersma, {Edine W.} and Bronzwaer, {Stef L A M} and Outi Lyytik{\"a}inen and Degener, {John E.} and Paul Schrijnemakers and Nienke Bruinsma and Jos Monen and Wolfgang Witte and Hajo Grundmann and H. Mittermayer and W. Koller and H. Goossens and E. Hendrickx and B. Markova and S. Kalenic and A. Tambic-Andrasevic and P. Urbaskova and D. Monnet and P. Naaber and O. Lyytik{\"a}inen and A. Nissinen and H. Aubry-Damon and P. Courvalin and U. Buchholz and W. Witte and N. Legakis and G. Vatopoulos and M. F{\"u}zi and D. O'Flanagan and O. Murphy and K. Kristinsson and R. Raz and G. Cornaglia and P. D'Ancona and R. Hemmer and M. Borg and {De Neeling}, A. and E. Tiemersma and A. Hoiby and E. Bj{\o}rl{\o}w and W. Hryniewicz and M. Cani{\cc}a and I. Codita and M. Gubina and J. Kolman and L. Langsadl and F. Baquero and J. Campos and B. Liljequist and A. Johnson and M. Whale",
year = "2004",
month = "9",
language = "English",
volume = "10",
pages = "1627--1634",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "9",

}

TY - JOUR

T1 - Methicillin-resistant staphylococcus aureus in Europe, 1999-2002

AU - Tiemersma, Edine W.

AU - Bronzwaer, Stef L A M

AU - Lyytikäinen, Outi

AU - Degener, John E.

AU - Schrijnemakers, Paul

AU - Bruinsma, Nienke

AU - Monen, Jos

AU - Witte, Wolfgang

AU - Grundmann, Hajo

AU - Mittermayer, H.

AU - Koller, W.

AU - Goossens, H.

AU - Hendrickx, E.

AU - Markova, B.

AU - Kalenic, S.

AU - Tambic-Andrasevic, A.

AU - Urbaskova, P.

AU - Monnet, D.

AU - Naaber, P.

AU - Lyytikäinen, O.

AU - Nissinen, A.

AU - Aubry-Damon, H.

AU - Courvalin, P.

AU - Buchholz, U.

AU - Witte, W.

AU - Legakis, N.

AU - Vatopoulos, G.

AU - Füzi, M.

AU - O'Flanagan, D.

AU - Murphy, O.

AU - Kristinsson, K.

AU - Raz, R.

AU - Cornaglia, G.

AU - D'Ancona, P.

AU - Hemmer, R.

AU - Borg, M.

AU - De Neeling, A.

AU - Tiemersma, E.

AU - Hoiby, A.

AU - Bjørløw, E.

AU - Hryniewicz, W.

AU - Caniça, M.

AU - Codita, I.

AU - Gubina, M.

AU - Kolman, J.

AU - Langsadl, L.

AU - Baquero, F.

AU - Campos, J.

AU - Liljequist, B.

AU - Johnson, A.

AU - Whale, M.

PY - 2004/9

Y1 - 2004/9

N2 - We explored the variation in proportions of methicillin-resistant Staphylococcus aureus (MRSA) between and within countries participating in the European Antimicrobial Resistance Surveillance System and temporal trends in its occurrence. This system collects routine antimicrobial susceptibility tests for S. aureus. We examined data collected from January 1999 through December 2002 (50,759 isolates from 495 hospitals in 26 countries). MRSA prevalence varied almost 100-fold, from 40% in southern and western Europe. MRSA proportions significantly increased in Belgium, Germany, Ireland, the Netherlands, and the United Kingdom, and decreased in Slovenia. Within countries, MRSA proportions varied between hospitals with highest variance in countries with a prevalence of 5% to 20%. The observed trends should stimulate initiatives to control MRSA at national, regional, and hospital levels. The large differences between hospitals indicate that efforts may be most effective at regional and hospital levels.

AB - We explored the variation in proportions of methicillin-resistant Staphylococcus aureus (MRSA) between and within countries participating in the European Antimicrobial Resistance Surveillance System and temporal trends in its occurrence. This system collects routine antimicrobial susceptibility tests for S. aureus. We examined data collected from January 1999 through December 2002 (50,759 isolates from 495 hospitals in 26 countries). MRSA prevalence varied almost 100-fold, from 40% in southern and western Europe. MRSA proportions significantly increased in Belgium, Germany, Ireland, the Netherlands, and the United Kingdom, and decreased in Slovenia. Within countries, MRSA proportions varied between hospitals with highest variance in countries with a prevalence of 5% to 20%. The observed trends should stimulate initiatives to control MRSA at national, regional, and hospital levels. The large differences between hospitals indicate that efforts may be most effective at regional and hospital levels.

UR - http://www.scopus.com/inward/record.url?scp=4444271222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444271222&partnerID=8YFLogxK

M3 - Article

C2 - 15498166

AN - SCOPUS:4444271222

VL - 10

SP - 1627

EP - 1634

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 9

ER -